Last reviewed · How we verify

Ginkgo leaf dropping pill — Competitive Intelligence Brief

Ginkgo leaf dropping pill (Ginkgo leaf dropping pill) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal extract / Traditional medicine. Area: Neurology / Cognitive disorders.

marketed Herbal extract / Traditional medicine Neurology / Cognitive disorders Small molecule Live · refreshed every 30 min

Target snapshot

Ginkgo leaf dropping pill (Ginkgo leaf dropping pill) — Wanbangde Pharmaceutical Group Co., LTD. Ginkgo leaf extract improves blood circulation and reduces blood viscosity to enhance cerebral blood flow and oxygen delivery.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ginkgo leaf dropping pill TARGET Ginkgo leaf dropping pill Wanbangde Pharmaceutical Group Co., LTD marketed Herbal extract / Traditional medicine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal extract / Traditional medicine class)

  1. Wanbangde Pharmaceutical Group Co., LTD · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ginkgo leaf dropping pill — Competitive Intelligence Brief. https://druglandscape.com/ci/ginkgo-leaf-dropping-pill. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing